DuPont Sustainable Solutions Becomes DSS+

DuPont Sustainable Solutions has been rebranded as DSS+ with effect from Feb. 28. After separating from parent DuPont in September 2019 in a spinoff backed by Swiss private equity group Gyrus Capital, the company became an independent consulting firm to industrial sectors such as chemicals, oil & gas, mining, metals and manufacturing.

Davide Vassallo, CEO of DSS+, said the new brand name “represents the exponential capability we have to help companies work safer and smarter, with purpose and impact.”

Since being spun out, DSS+ said it has evolved and enhanced its capabilities both through organic growth and three acquisitions to improve the breadth and depth of capabilities in operational excellence, sustainability and environmental, social & governance (ESG).

The acquisitions included Sofies Group last October, adding new intellectual property, methodologies, tools and capabilities in sustainability management, KKS advisors in July 2021, a leader in ESG with particular expertise in financing and investment, and global consulting firm Lodestone Partners in February 2020.

DSS+ said it has more than 1,000 professionals operating in 40 countries worldwide.

Author: Elaine Burridge, Freelance Journalist

(c) dss+
(c) dss+

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.